Cardiac Wire #309 October 2, 2025
HFSA 2025 Round-Up, Intelerad to the Cloud, and AngioSafe
Cardiac Wire #308 September 29, 2025
CVD’s Global Burden, FDA Cracks Down, and Philips + Optum
Cardiac Wire #307 September 25, 2025
Meds-to-Beds for PCSK9is, CELEBRATE results, and Cigna Covers Plaque AIs
Cardiac Wire #306 September 22, 2025
MI in Young Patients, Medicare’s AI Rejections, and African CVH
Cardiac Wire #305 September 18, 2025
Patient Physician Communication, Nasal Diuretic, and Pharma Ads
Cardiac Wire #304 September 15, 2025
AI Stethoscopes Work, Infant BAV, and Apple’s Hypertension Detection
Cardiac Wire #303 September 11, 2025
ASE 2025 Highlights, VEST for PAH, and BSCI’s Bioenevelope Play
Cardiac Wire #302 September 8, 2025
Edwards Acquires Vectorious, FFR Revascularization, and Remote AFib Diagnosis
Cardiac Wire #301 September 4, 2025
ODYSSEY vs. MAPLE, ESC Highlights, and Kardium’s FDA Approval
Cardiac Wire #300 August 28, 2025
Cardiology Lifestyle Woes, AI for Heart Block, and DAPT Differences
Cardiac Wire #299 August 25, 2025
Real-World GLP Cost, Rocket Off Hold, and TAVR Deterioration
Cardiac Wire #298 August 21, 2025
CSP for AV Block, Generic Entresto, and Self-Plagiarism
Cardiac Wire #297 August 18, 2025
Rivaroxaban for AFib + CAD, HF is Preventable, and PFA’s Phrenic Compilation
Cardiac Wire #296 August 14, 2025
TEER for AFMR, Recall Rampage, and Plane Noise BP
Cardiac Wire #295 August 11, 2025
TAVR in 2025, FTC vs. Edwards, and Pregablin’s HF Link
Cardiac Wire #294 August 7, 2025
Lilly Outdoes Itself, Leqvio Monotherapy, and OMRON HF Detection
Cardiac Wire #293 August 4, 2025
Pre/Post-CVD Activity, COVID vs. Flu Heart, and Aging Arteries
Cardiac Wire #292 July 31, 2025
AZ’s Anselamimab Hurdle, GDMT Improves HF, and Roche Cuts CT-173
Cardiac Wire #291 July 28, 2025
